fundraising
NUZ
Offer Open
Neurizon Therapeutics Strengthens Capital with $6.3M Raise
Neurizon Therapeutics has raised $4.3 million through a placement and launched a $2 million share purchase plan.
November 6, 2026
Share:

Neurizon Therapeutics (ASX: NUZ) has successfully raised $4.3 million via a placement of 63.2 million shares at $0.068 per share. The company has also launched a $2 million share purchase plan to simplify its capital structure and fund the continued development of its NUZ-001 clinical program through mid-2027.
Capital Raise
Biotech
ASX

